Dimensional Fund Advisors LP Adaptive Biotechnologies Corp Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,389,688 shares of ADPT stock, worth $21.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,389,688

Previous 1,424,672 2.46%

Holding current value

$21.5 Million

Previous $10.6 Million 52.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$6.83 - $12.16 $238,940 - $425,405	-34,984 Reduced 2.46%	1,389,688 $16.2 Million
Q1 2025 May 13, 2025	SELL	$6.07 - $8.66 $1.09 Million - $1.56 Million	-180,204 Reduced 11.23%	1,424,672 $10.6 Million
Q4 2024 Feb 13, 2025	BUY	$4.37 - $6.78 $803,559 - $1.25 Million	183,881 Added 12.94%	1,604,876 $9.63 Million
Q3 2024 Nov 07, 2024	BUY	$3.37 - $5.12 $174,896 - $265,717	51,898 Added 3.79%	1,420,995 $7.28 Million
Q2 2024 Aug 09, 2024	SELL	$2.34 - $3.96 $876,374 - $1.48 Million	-374,519 Reduced 21.48%	1,369,097 $4.96 Million
Q1 2024 May 10, 2024	SELL	$2.88 - $4.8 $1.14 Million - $1.89 Million	-394,575 Reduced 18.45%	1,743,616 $5.6 Million
Q4 2023 Feb 07, 2024	SELL	$3.46 - $5.33 $529,331 - $815,415	-152,986 Reduced 6.68%	2,138,191 $10.5 Million
Q3 2023 Nov 09, 2023	BUY	$5.07 - $8.44 $716,041 - $1.19 Million	141,231 Added 6.57%	2,291,177 $12.5 Million
Q2 2023 Aug 09, 2023	BUY	$6.19 - $8.78 $3.1 Million - $4.4 Million	501,585 Added 30.43%	2,149,946 $14.4 Million
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $4.9 Million - $6.36 Million	628,622 Added 61.65%	1,648,361 $14.6 Million
Q4 2022 Feb 09, 2023	BUY	$6.26 - $9.34 $2.12 Million - $3.16 Million	338,662 Added 49.72%	1,019,739 $7.79 Million
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $1.73 Million - $3.37 Million	265,593 Added 63.92%	681,077 $4.85 Million
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $303,616 - $698,791	-47,440 Reduced 10.25%	415,484 $3.36 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $117,230 - $334,777	-11,584 Reduced 2.44%	462,924 $6.43 Million
Q4 2021 Feb 09, 2022	BUY	$25.17 - $36.85 $6.67 Million - $9.76 Million	264,902 Added 126.38%	474,508 $13.3 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $2.51 Million - $3.33 Million	83,549 Added 66.28%	209,606 $7.12 Million
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $271,775 - $376,116	-8,435 Reduced 6.27%	126,057 $5.15 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $1.89 Million - $3.43 Million	50,701 Added 60.51%	134,492 $5.41 Million
Q4 2020 Feb 25, 2021	BUY	$45.01 - $65.47 $3.77 Million - $5.49 Million	83,791 New	83,791 $4.96 Million

Others Institutions Holding ADPT

# of Institutions

264

Shares Held

149M

Call Options Held

168K

Put Options Held

25.2K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $2.21B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Adaptive Biotechnologies Corp Transaction History